Steven A. Marshall
About
Steven A. Marshall is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology.
According to data from OpenAlex, Steven A. Marshall has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Medicine, 20 papers in Infectious Diseases and 17 papers in Pharmacology. Recurrent topics in Steven A. Marshall's work include Antibiotic Resistance in Bacteria (23 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Steven A. Marshall is often cited by papers focused on Antibiotic Resistance in Bacteria (23 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Steven A. Marshall collaborates with scholars based in United States and Germany. Steven A. Marshall's co-authors include Ronald N. Jones, Michael A. Pfaller, Werner W. Wilke, Martin Cormican, Michael B. Edmond, R. J. Hollis, Ronald N. Jones, Stacy L. Coffman, Richard P. Wenzel and Tam T. Van and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.
In The Last Decade
Steven A. Marshall
39 papers receiving 1.3k citations
Peers
Steven A. Marshall
Laurent Bret France
Hosam M. Zowawi Australia
Rachel Pike United Kingdom
L. A. McDermott United States
Eugenio A. Debbia Italy
Pilar Retamar Spain
E.-C. Kim South Korea
Tsigereda Tekle United States
Óscar Cuevas Spain
Carmen Betriú Spain
Citations per year, relative to Steven A. Marshall Steven A. Marshall (= 1×)
peers
Laurent Bret
Countries citing papers authored by Steven A. Marshall
Since
Specialization
Citations
This map shows the geographic impact of Steven A. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Marshall more than expected).
Fields of papers citing papers by Steven A. Marshall
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Steven A. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Marshall. The network helps show where Steven A. Marshall may publish in the future.
Co-authorship network of co-authors of Steven A. Marshall
This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Marshall. A scholar is included among the top collaborators of Steven A. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Marshall. Steven A. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Graitcer, Samuel B., Larisa V. Gubareva, Laurie Kamimoto, et al.. (2010). Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States. Emerging infectious diseases. 17(2). 255–257.
2.
Burns, Jane L., Lisa Saiman, Susan Whittier, et al.. (2001). Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagnostic Microbiology and Infectious Disease. 39(4). 257–260.
3.
Jones, Ronald N., Steven A. Marshall, & M E Erwin. (1999). Antimicrobial activity and spectrum of SCH27899 (ziracin®) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Diagnostic Microbiology and Infectious Disease. 34(2). 103–110.
4.
Jones, Ronald N., Yao-Shen Chen, & Steven A. Marshall. (1998). Comparative in vitro activity of alexomycin (U-82127) tested against Escherichia coli, Salmonella spp., and enterococci of animal and human origin. Clinical Microbiology and Infection. 4(10). 601–603.
5.
Jones, Ronald N., Douglas J. Biedenbach, Steven A. Marshall, Michael A. Pfaller, & Gary V. Doern. (1998). Evaluation of the Vitek System to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime. Diagnostic Microbiology and Infectious Disease. 32(2). 107–110.
6.
Jones, Ronald N., et al.. (1998). Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel β-lactamase inhibitors (Ro 48-5545 and Ro 48-8724). Diagnostic Microbiology and Infectious Disease. 32(2). 85–94.
7.
Marshall, Steven A., et al.. (1998). In Vitro Activity of Cefepime and Other Broad-Spectrum β-Lactams Tested Against 129 mec A-negative Staphylococcus spp. Isolates: A Multicenter Sample. Diagnostic Microbiology and Infectious Disease. 30(1). 65–69.
8.
Marshall, Steven A., Werner W. Wilke, Michael A. Pfaller, & Ronald N. Jones. (1998). Staphylococcus aureus and Coagulase-Negative Staphylococci from Blood Stream Infections: Frequency of Occurrence, Antimicrobial Susceptibility, and Molecular (mecA) Characterization of Oxacillin Resistance in the SCOPE Program. Diagnostic Microbiology and Infectious Disease. 30(3). 205–214.
9.
Pfaller, Michael A., Steven A. Marshall, & Ronald N. Jones. (1997). In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: A multicenter sample. Diagnostic Microbiology and Infectious Disease. 29(4). 273–276.
10.
Pfaller, Michael A., Ronald N. Jones, Steven A. Marshall, et al.. (1997). Inducible amp C β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagnostic Microbiology and Infectious Disease. 28(4). 211–219.
11.
Pfaller, Michael A., Ronald N. Jones, Steven A. Marshall, Michael B. Edmond, & Richard P. Wenzel. (1997). Nosocomial streptococcal blood stream infections in the SCOPE program: Species occurrence and antimicrobial resistance. Diagnostic Microbiology and Infectious Disease. 29(4). 259–263.
12.
Marshall, Steven A., Paul R. Rhomberg, & Ronald N. Jones. (1997). Comparative evaluation of etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents An investigation using U.S. food and drug administration regulatory criteria. Diagnostic Microbiology and Infectious Disease. 27(3). 93–97.
13.
Jones, Ronald N., Steven A. Marshall, Michael A. Pfaller, et al.. (1997). Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. Diagnostic Microbiology and Infectious Disease. 29(2). 95–102.
14.
Wilke, Werner W., Steven A. Marshall, Stacy L. Coffman, et al.. (1997). Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diagnostic Microbiology and Infectious Disease. 29(1). 43–49.
15.
Jones, Ronald N., Steven A. Marshall, & Loukia Zerva. (1997). Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods. Diagnostic Microbiology and Infectious Disease. 28(1). 35–40.
16.
Cormican, Martin, M E Erwin, Steven A. Marshall, & Ronald N. Jones. (1996). Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis. Diagnostic Microbiology and Infectious Disease. 24(3). 155–160.
17.
Marshall, Steven A., Larry D. Sutton, & Ronald N. Jones. (1995). Evaluation of S1 chromogenic cephalosporin β-lactamase disk assay tested against Gram-positive anaerobes, coagulase-negative staphylococci, Prevotella spp. and Enterococcus spp.. Diagnostic Microbiology and Infectious Disease. 22(4). 353–355.
18.
Cormican, Martin, Steven A. Marshall, & Ronald N. Jones. (1995). Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin). Diagnostic Microbiology and Infectious Disease. 21(1). 51–54.
19.
Cormican, Martin, Steven A. Marshall, & Ronald N. Jones. (1995). Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents. Diagnostic Microbiology and Infectious Disease. 23(4). 157–160.
20.
Marshall, Steven A., Ronald N. Jones, Patrick R. Murray, et al.. (1993). In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. Journal of Antimicrobial Chemotherapy. 32(6). 877–884.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Laurent Bret Breakdown of academic impact, for papers by Hosam M. Zowawi Breakdown of academic impact, for papers by Rachel Pike Breakdown of academic impact, for papers by L. A. McDermott Breakdown of academic impact, for papers by Eugenio A. Debbia Breakdown of academic impact, for papers by Pilar Retamar Breakdown of academic impact, for papers by E.-C. Kim Breakdown of academic impact, for papers by Tsigereda Tekle Breakdown of academic impact, for papers by Óscar Cuevas Breakdown of academic impact, for papers by Carmen Betriú